dic1 Antibody

What is DISC1 and why is it significant in neuroscience research?

DISC1 (Disrupted in Schizophrenia-1) was originally identified through a balanced chromosomal translocation t(1;11)(q42.1;q14.3) in a Scottish pedigree with various psychiatric disorders . It has emerged as a critical risk gene for psychiatric conditions including schizophrenia and bipolar disorder . DISC1 plays essential roles in embryonic neurogenesis, neuronal migration, axon differentiation, and synapse formation, while also modulating the genesis and circuit integration of new neurons in the adult brain . Its study provides insights into the neurodevelopmental basis of psychiatric disorders.

What types of DISC1 antibodies are available for research applications?

Research-grade DISC1 antibodies include species-specific variants such as:

• Mouse Anti-Human DISC1 Monoclonal Antibody (Clone #685920, targeting recombinant human DISC1 Lys101-Arg260)

• Sheep Anti-Human DISC1 Antigen Affinity-purified Polyclonal Antibody (targeting recombinant human DISC1 Lys101-Arg260)
  These antibodies recognize specific epitopes and demonstrate validated reactivity in various experimental applications.

What is the expression pattern of DISC1 in human brain tissue?

Immunohistochemical analyses reveal that DISC1 is prominently expressed in neuronal cell bodies in the human hippocampus . When using Mouse Anti-Human DISC1 Monoclonal Antibody at 15 μg/mL, specific staining localizes to neuronal cell bodies . With Sheep Anti-Human DISC1 Antibody (10 μg/mL), staining is specifically localized to neuronal cytoplasm . This expression pattern is consistent with DISC1's role in neuronal development and function.

What are the optimal protocols for detecting DISC1 using Western blot?

Table 1: Optimized Western Blot Parameters for DISC1 Detection

For optimal results, lysates should be prepared fresh, and heat-induced protein denaturation should be carefully controlled to maintain epitope integrity . The detection of DISC1 at approximately 100-105 kDa confirms antibody specificity and target validity.

How should researchers optimize immunohistochemistry protocols for DISC1 detection in brain tissue?

For successful IHC detection of DISC1 in paraffin-embedded brain sections, the following protocol is recommended:

• Perform heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic

• For Mouse Anti-Human DISC1: Use at 15 μg/mL concentration, incubate overnight at 4°C

• For Sheep Anti-Human DISC1: Use at 10 μg/mL concentration, incubate overnight at 4°C

• Apply appropriate HRP-DAB staining system (Anti-Mouse or Anti-Sheep)

• Counterstain with hematoxylin for nuclear visualization

This approach yields specific staining in neuronal cell bodies and cytoplasm, particularly in hippocampal regions, with minimal background interference.

What controls should be incorporated when validating DISC1 antibody specificity?

A comprehensive validation strategy should include:

• Positive controls: HeLa, Raji, Daudi, and Ramos cell lysates show reliable DISC1 expression

• Negative controls: Omission of primary antibody to assess secondary antibody specificity

• Peptide competition assays: Pre-incubation with immunizing peptide (Lys101-Arg260) should abolish signal

• Cross-reactivity assessment: Testing across multiple species if applicable

• Knockout/knockdown validation: When possible, comparing signal in DISC1-depleted samples

This multi-faceted approach ensures antibody specificity and experimental reproducibility .

How does DISC1 interact with DIX domain containing-1 (Dixdc1) during neural development?

Biochemical studies demonstrate that DISC1 and Dixdc1 co-immunoprecipitate in embryonic day 14 (E14) brain tissue, forming a functional complex in vivo . Domain mapping experiments reveal that:

• Dixdc1 binds most strongly to the C-terminus of DISC1 and weakly to its middle region

• DISC1 strongly binds to the N-terminal Dixdc1 region between the calpain homology and coiled-coil domains

This interaction appears critical for regulating neural progenitor proliferation and neuronal migration during embryonic cortical development. The temporal expression pattern shows both long and short isoforms of Dixdc1 are highly expressed from E10 through the neurogenic period (E11-17), with the short isoform downregulated to nearly undetectable levels after E18 .

What are the challenges in detecting different DISC1 isoforms and how can researchers overcome them?

DISC1 exists in multiple isoforms with varying molecular weights, which presents challenges for comprehensive detection. Researchers should:

• Use antibodies targeting conserved regions when studying all isoforms

• Select isoform-specific antibodies when investigating particular variants

• Combine immunoprecipitation with mass spectrometry for unbiased isoform profiling

• Optimize SDS-PAGE conditions (gradient gels, extended run times) to resolve closely migrating isoforms

• Consider using isoform-specific primers for RT-PCR validation of protein findings

The antibodies described target the Lys101-Arg260 region of human DISC1, which may not detect all splice variants equally .

How can researchers study DISC1's role in psychiatric disorders using these antibodies?

A multidimensional research strategy includes:

• Comparative tissue analysis: Examining DISC1 expression and localization in post-mortem brain tissue from psychiatric patients versus controls

• Genetic model systems: Using DISC1 antibodies to validate transgenic or mutant models expressing disease-associated DISC1 variants

• Interaction proteomics: Immunoprecipitating DISC1 complexes followed by mass spectrometry to identify altered protein interactions in disease states

• Phosphorylation analysis: Using phospho-specific antibodies alongside total DISC1 antibodies to assess regulatory changes

• Circuit-specific analysis: Combining DISC1 immunohistochemistry with neural circuit tracing in relevant brain regions

Research has demonstrated that DISC1 dysfunction impacts neurogenesis, neuronal migration, and synapse formation, which may contribute to the neurodevelopmental basis of psychiatric disorders .

How should researchers address non-specific binding when using DISC1 antibodies?

When encountering non-specific bands or background staining:

• Optimize antibody concentration through careful titration experiments

• Increase blocking stringency (5% BSA or milk, with addition of 0.1-0.3% Triton X-100)

• Extend washing steps (minimum 3×10 minutes with gentle agitation)

• Consider adding competing proteins to reduce non-specific interactions

• For Western blots, compare reducing versus non-reducing conditions as reduction state can affect epitope availability

• For IHC applications, optimize antigen retrieval methods and duration

These optimization steps should be systematically tested and documented to establish reproducible protocols.

What considerations are important when comparing results across different DISC1 antibodies?

When using multiple DISC1 antibodies or comparing results with literature:

• Epitope differences: Different antibodies recognize distinct DISC1 regions, potentially yielding different staining patterns

• Antibody formats: Monoclonal antibodies (e.g., MAB6699) offer high specificity but may miss certain isoforms, while polyclonal antibodies (e.g., AF6699) recognize multiple epitopes

• Species cross-reactivity: Verify whether antibodies cross-react with DISC1 from model organisms

• Application optimization: Each antibody requires specific protocol optimization for WB, IHC, IP, etc.

• Batch variation: Include lot number information when reporting results

Researchers should validate findings using complementary approaches when possible, such as combining protein detection with mRNA analysis or functional assays .

How can researchers quantify DISC1 expression levels accurately in experimental models?

For precise quantification:

• Standardized loading controls: Use consistently expressed proteins (β-actin, GAPDH) or total protein staining (Ponceau S)

• Multiple internal controls: Include calibration samples on each blot/slide for inter-assay normalization

• Dynamic range assessment: Create standard curves with recombinant DISC1 to ensure measurements fall within linear detection range

• Digital image analysis: Use appropriate software with background subtraction and region-of-interest tools

• Statistical validation: Apply appropriate statistical tests accounting for technical and biological replication

For Western blots, DISC1 appears as a ~100-105 kDa band under reducing conditions, which should be the focus of quantification efforts .

How can DISC1 antibodies be applied in patient-derived models of psychiatric disorders?

Innovative applications include:

• Examining DISC1 expression and localization in patient-derived iPSCs and differentiated neurons

• Correlating DISC1 aggregation status with cellular phenotypes in patient-derived models

• Monitoring DISC1-interacting proteins in healthy versus patient-derived cells

• Assessing DISC1 responses to pharmacological interventions in patient cells

• Combining DISC1 immunostaining with electrophysiological recordings in patient-derived neurons

These approaches may provide insights into patient-specific disease mechanisms and potential personalized therapeutic strategies.

What advances in DISC1 antibody technology are enhancing neurodevelopmental research?

Recent methodological innovations include:

• Super-resolution microscopy-compatible antibodies: Allowing nanoscale visualization of DISC1 localization

• Proximity labeling approaches: Using DISC1 antibodies in combination with BioID or APEX2 systems to map the local proteome

• Multiplex immunostaining: Combining DISC1 detection with other markers to assess pathway activation

• In vivo imaging applications: Development of DISC1 antibody fragments for live imaging

• Conformation-specific antibodies: Detecting specific structural states of DISC1 that may be associated with pathology

These technological advances expand the research applications of DISC1 antibodies beyond traditional biochemical and histological approaches.